Sano Genetics
Sano Genetics is a personalised medicine research platform with data privacy and transparency at its core.
Sano Genetics has raised €23M across 3 funding rounds from 7 investors, most recently a round in Jan 2024. Based in Cambridge, UK; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€23M
€23,355,664
Funding rounds
3
Investors
7
distinct backers
Active since
2021-01
latest 2024-01
Funding by year
EUR raised per yearSano Genetics — funding by year — interactive chart.
Data table
| Sano Genetics — funding by year | |
|---|---|
| 2021 | €2.8M |
| 2022 | €10M |
| 2024 | €11M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-22 | Other | €11M | Episode 1,MMC Ventures,Plural,Seedcamp | View deal → |
| 2022-03-28 | Series A | €10M | Episode 1,Margo Georgiadis,MMC Ventures,Paul Forster,Paul Wicks,Seedcamp | View deal → |
| 2021-01-25 | Seed | €2.8M | Episode 1 | View deal → |